Folate-modified liposomes for co-delivery of schisandrin A and oxaliplatin to enhance colorectal cancer cell death
{{output}}
The incidence of colorectal cancer (CRC) poses a significant threat to human life. Immunotherapy has emerged as an efficacious treatment against CRC. However, it is hindered by the challenge of inadequate immunogenicity. In addition to exerting inhibitory effe... ...
